In conclusion, using an integrative systems biological approach, we determined the role of EPO signaling pathway in ccRCC progression, and identified an undesired role of KIAA0101 in ccRCC proliferation and migration induced by EPO, which have not previously been linked KIAA0101 to kidney cancer cachexia elicited by EPO. The gene discussed is EPO; the disease is kidney cancer.